Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹245 Cr₹265 Cr₹246 Cr₹207 Cr₹167 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH is ₹245 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹245 Cr
Mar2024₹265 Cr
Mar2023₹246 Cr
Mar2022₹207 Cr
Mar2021₹167 Cr

How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹245 Cr
-7.89
Mar2024 ₹265 Cr
7.91
Mar2023 ₹246 Cr
18.57
Mar2022 ₹207 Cr
24.37
Mar2021 ₹167 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,014.3 Cr 0% -4.2% -37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -1% 2.5% -4.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

0%

-4.2%

-37%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses